 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oppenheimer restated their outperform rating on shares of Achieve Life Sciences (NASDAQ:ACHV - Free Report) in a research report sent to investors on Monday morning, Benzinga reports. They currently...

Achieve Life Sciences (NASDAQ:ACHV) Given Outperform Rating at Oppenheimer

This indicator may be signaling that ACHV's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Achieve Life Sciences (ACHV, $4.58) entered Downtrend as Momentum indicator drops below 0 level on Apr 01, 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
ACHV stock results show that Achieve Life Sciences beat analyst estimates for earnings per share the fourth quarter of 2023.
The post...

ACHV Stock Earnings: Achieve Life Sciences Beats EPS for Q4 2023

Q4 2023 Achieve Life Sciences Inc Earnings Call Transcript

Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript...

Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript

ACHV Aligns with EPS Projections, Focuses on Cytisinicline DevelopmentRelated Stocks: ACHV...

Achieve Life Sciences Inc Reports Year-End Loss, Progresses Towards FDA Approval

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Achieve Life Sciences reports Q4 EPS (26c), consensus (31c)

Company to host conference call at 4:30 PM EDT today, Thursday, March 28, 2024SEATTLE and VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV...

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update

Achieve Life Sciences Q4 2023 Earnings Preview...

Achieve Life Sciences Q4 2023 Earnings Preview

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Volume (M)	77,779.00
52-Wk High	$10.30
52-Wk Low	$3.03

ACHV Achieve Life Sciences Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals